Replies to post #788375 on NorthWest Biotherapeutics Inc (NWBO)

[Barunuuk]

With the CHEAP acquisition of Advent alone, NWBO is worth >$10 a share, with approval, they are now worth >$100 share. You kidding me? Immunotherapy is projected to see a market of $500 BILLION BY 2030. And NWBO is the leading drug candidate for ALL IMMUNOTHERAPY! So yeah, $100 a share is minimum!!